Back to results
US 2015/0094264 A1Published application
Use of obestatin for muscle regeneration
AssigneesUniversidade De Santiago De Compostela, Servizo Galego De SAúDe
InventorsJesús Pérez Camiña, Felipe Casanueva Freijo
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of obestatin, or to the nucleotide sequence that codes for same, as an in vitro myogenic agent, and for the production of a drug for muscle regeneration, preferably for musculoskeletal regeneration, thus being useful in the treatment and/or prevention of degenerative or genetic diseases or of lesions that present with muscle damage.
Claims23
A myogenic agent comprising an isolated peptide comprising an amino acid sequence with at least 86% identity to SEQ ID NO:
- 1, or the nucleotide sequence encoding an amino acid sequence with at least 86% identity to SEQ ID NO:
- 1.
-9. (canceled)
-19. (canceled)
-34. (canceled)
Dependencies are inferred from the claim text.